|6 Months Ended||12 Months Ended|
Jun. 30, 2021
Dec. 31, 2020
|8. SHAREHOLDERS' EQUITY||
8. SHAREHOLDERS’ EQUITY
The table below details the change in Company shares outstanding by class during the six months ended June 30, 2021:
(1) Excluded 390 warrants issuable should underwriter options be exercised.
12. SHAREHOLDERS’ EQUITY
The table below details the change in Company shares outstanding by class during the year ended December 31, 2020:
In December 2020, the Company complete a CAD$34.5 million share offering resulting in the issuance of 11.5 million subordinate voting shares priced at CAD$1.50 per share. The offering resulting in approximately $25 million in proceeds, net of offering expenses. The use of proceeds were for the development of a cultivation and production facility and working capital and other corporate purposes.
As discussed in Note 4, in consideration for the acquisition of Mezzotin in connection with the reverse takeover, Indus issued 130 shares of Indus subordinate voting shares representing $1,513 total value based on the concurrent financing subscription price of CAD$15.65 (US$11.60). The excess of the purchase price over net assets acquired was charged to the consolidated statements of operations as RTO expense in general and administrative expenses.
A reconciliation of the beginning and ending balance of warrants outstanding is as follows:
(1) Excludes 553 warrants issuable should underwriter options be exercised.
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef